By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Proteome Sciences and the Moffitt Cancer Center have struck a partnership to research ways to develop assays that can be adapted for analyzing tumors, the UK-based company said today.

Proteome Sciences said it will work with Moffitt, located in Tampa, Fla., to develop mass spectrometry assays that can measure important signalling and repair pathway proteins for use in tumor biopsy analysis in the clinic.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.